Cost-Effectiveness Analysis Evaluating Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.11.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Economic Evaluation of Fidaxomicin Compared With Vancomycin in the Treatment of Clostridium Difficile Infection

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pin8 - Comparative Efficacy of Fidaxomicin, Vancomycin and Metronidazole for the Treatment of Clostridium Difficile Infection: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vancomycin Enema in the Treatment of Clostridium Difficile Infection

Surgical Infections
SurgeryInfectious DiseasesMicrobiology
2019English

Prolonged Oral Vancomycin for Secondary Prophylaxis of Relapsing Clostridium Difficile Infection

BMC Infectious Diseases
Infectious Diseases
2019English

Cost-Effectiveness Analysis of Endovascular Versus Neurosurgical Treatment for Ruptured Intracranial Aneurysms in the United States

Journal of Neurosurgery
SurgeryNeurology
2009English

Fidaxomicin for Clostridium Difficile-Associated Diarrhoea

Clinical Drug Investigation
MedicinePharmacology
2012English

Pms38 - Cost Effectiveness Analysis of Secukinumab Versus Ustekinumab for the Treatment of Psoriatic Arthritis in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Fidaxomicin in the Treatment of Colitis Due to Clostridium Difficile: Preliminary Results

Clinical Management Issues
MedicineAccountingManagementBusiness
2014English

Current and Emerging Management Options for Clostridium Difficile Infection: What Is the Role of Fidaxomicin?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy